Investigation and Management of Non-immune Fetal Hydrops

Journal of Obstetrics and Gynaecology Canada

Volumn 35, Issue 10, 2013, Pages 923-936

  Désilets, Valérie ^a   Audibert, François ^a   Wilson, R ^a   Audibert, Francois ^a   Brock, Jo Ann ^a   Carroll, June ^a   Cartier, Lola ^a   Gagnon, Alain ^a   Johnson, Jo Ann ^a   Langlois, Sylvie ^a   MacDonald, William ^a   Murphy Kaulbeck, Lynn ^a   Okun, Nanette ^a   Pastuck, Melanie ^b   Senikas, Vyta ^a  

^a NONE   (Canada)

^b NONE   (Canada)

Author keywords

AF amniotic fluid; CBC complete blood count; CMV cytomegalovirus; Fetal hydrops; Fetal metabolism; Fetal therapy; FISH fluorescent in situ hybridization; Hb hemoglobin; HbH hemoglobin H; MCA middle cerebral artery; MPS mucopolysaccharidosis; NICHD National Institute of Child Health and Human Development; NIHF non immune hydrops fetalis; Non immune hydrops fetalis; QF PCR quantitative fluorescent polymerase chain reaction; RT PCR real time polymerase chain reaction; TORCH toxoplasmosis, rubella, cytomegalovirus, herpes simplex; UA umbilical artery; VZV Varicella zoster virus

Indexed keywords

ALPHA THALASSEMIA; ANEMIA; ARTICLE; AUTOPSY; CHROMOSOME ANALYSIS; CLINICAL EVALUATION; CONGENITAL MALFORMATION; CYSTIC LYMPHANGIOMA; CYTOMEGALOVIRUS INFECTION; DISEASE CLASSIFICATION; DOPPLER FLOWMETRY; ECHOCARDIOGRAPHY; ERYTHEMA INFECTIOSUM; ETHNICITY; FETUS BLOOD SAMPLING; FETUS ECHOGRAPHY; FETUS HYDROPS; FIRST TRIMESTER PREGNANCY; GENETIC DISORDER; HERPES ZOSTER; HUMAN; INTRAUTERINE INFECTION; MANAGED CARE; MICROARRAY ANALYSIS; NON INVASIVE PROCEDURE; PATIENT COUNSELING; PATIENT REFERRAL; PRACTICE GUIDELINE; PRENATAL CARE; PROGNOSIS; RISK ASSESSMENT; RUBELLA; FEMALE; FETAL THERAPY; FETUS METABOLISM; NON-IMMUNE HYDROPS FETALIS; PREGNANCY; REVIEW; HYDROPS FETALIS;

FETAL HYDROPS; FETAL METABOLISM; FETAL THERAPY; NON-IMMUNE HYDROPS FETALIS;

AUTOPSY; ECHOCARDIOGRAPHY; FEMALE; HUMANS; HYDROPS FETALIS; PREGNANCY; PRENATAL CARE; PROGNOSIS; ULTRASONOGRAPHY, DOPPLER; ULTRASONOGRAPHY, PRENATAL;

EID: 84891719499     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(15)30816-1     Document Type: Article

References (78)

1. Machin G.A. Hydrops revisited: literature review 1414 cases published in the 1980s. Am J Med Gen A 1989, 34:366-390.
2. Machin G.A. Hydrops, cystic hygroma, hydrothorax, pericardial effusion and fetal ascites. In: Gilbert-Barness E, ed. Potter's pathology of the fetus and infant. St-Louis: Mosby; 1997.
3. Fung Kee Fung K., Eason E., Crane J., Armson A., De La Ronde S., Farine D. et al; SOGC Maternal-Fetal Medicine Committee; SOGC Genetics Committee. Prevention of Rh alloimmunization. SOGC Clinical Practice Guidelines, No. 133, September 2003. J Obstet Gynaecol Can 2003, 25:765-773.
4. Mari G., Deter R.L., Carpenter R.L., Rahman F., Zimmerman R., Moise K.J., et al. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses. N Engl J Med 2000, 342:9-14.
5. Hansen T. Non immune hydrops fetalis.In: 2003, Rudolph's pediatrics.McGraw-Hill, New York. 21st ed. A. Rudolph, R. Kamei, K. Overby (Eds.).
6. Ismail K.M., Martin W.L., Ghosh S., Whittle M.J., Kilby M.D. Etiology and outcome of hydrops fetalis. J Matern Fetal Med 2001, 10:175-181.
7. Milunsky A. Genetic disorders of the fetus: diagnosis, prevention and treatment 2004, John Hopkins University Press, Baltimore. 5th ed.
8. Kharrat R., Yamamoto M., Roume J., Couderc S., Vialard F., Hillion Y., et al. Karyotype and outcome of fetuses diagnosed with cystic hygroma in the first trimester in relation to nuchal translucency thickness. Prenat Diagn 2006, 26:369-372.
9. Molina F.S., Avgidou K., Kagan K.O., Poggi S., Nicolaides K.H. Cystic hygromas, nuchal edema, and nuchal translucency at 11-14 weeks of gestation. Obstet Gynecol 2006, 107:678-683.
10. Desilets V., Oligny L.L. Genetics Committee of the Society of Obstetricians and Gynaecology Canada; Family Physicians Advisory Committee; Medico-Legal Committee of the SOGC. Fetal and perinatal autopsy in prenatally diagnosed fetal abnormalities with normal karyotype. SOGC Clinical Practice Guidelines, No. 267,October 2011. J Obstet Gynaecol Can 2011, 33:1047-1057.
11. Gagnon A., Wilson R.D., Allen V.M., Audibert F., Blight C., Brock J.A., et al. Genetics Committee of the Society of Obstetricians and Gynaecologists of Canada. Evaluation of prenatally diagnosed structural congenital anomalies. SOGC Clinical Practice Guidelines, No. 234, September 2009. J Obstet Gynaecol Can 2009, 31:875-881.
12. Chitayat D., Langlois S., Wilson R.D. Genetics Committee of the Society of Obstetricians and Gynaecologists of Canada; Prenatal Diagnosis Committee of the Canadian College of Medical Geneticists. Prenatal screening for fetal aneuploidy in singleton pregnancies. SOGC Clinical Practice Guidelines, No. 261, July 2011. J Obstet Gynaecol Can 2011, 33:736-750.
13. Morin L., Lim K. SOGC Diagnostic Imaging Committee. Ultrasound in twin pregnancies. SOGC Clinical Practice Guidelines, No. 260, June 2011. J Obstet Gynaecol Can 2011, 33:643-656.
14. Senat M.V., Deprest J., Boulvain M., Paupe A., Winer N., Ville Y. Endoscopic laser surgery versus serial amnioreduction for severe twin-to-twin transfusion syndrome. N Engl J Med 2004, 351:136-144.
15. Yamamoto M., Ville Y. Twin-to-twin transfusion syndrome: management options and outcomes. Clin Obstet Gynecol 2005, 48:973-980.
16. Chalouhi G.E., Stirnemann J.J., Salomon L.J., Essaoui M., Quibel T., Ville Y. Specific complications of monochorionic twin pregnancies: twin-twin transfusion syndrome and twin reversed arterial perfusion sequence. Semin Fetal Neonatal Med 2010, 15:349-356.
17. Audibert F., GagnonM A. SOGC Genetics Committee; Prenatal Diagnosis Committee of the Canadian College of Medical Geneticists. Prenatal screening for and diagnosis of aneuploidy in twin pregnancies. SOGC Clinical Practice Guidelines, No. 262, July 2011. J Obstet Gynaecol Can 2011, 33:754-767.
18. Bellini C., Hennekam R.C., Bonioli E. A diagnostic flow chart for non-immune hydrops fetalis. Am J Med Genet A 2009, 149:852-853.
19. McCoy M.C., Katz V.L., Gould N., Kuller J.A. Non-immune hydrops after 20 weeks' gestation: review of 10 years' experience with suggestions for management. Obstet Gynecol 1995, 85:578-582.
20. Santo S., Mansour S., Thilaganathan B., Homfray T., Papageorghiou A., Calvert S., et al. Prenatal diagnosis of non-immune hydrops fetalis: what do we tell the parents?. Prenat Diagn 2011, 31:186-195.
21. Braun T., Brauer M., Fuchs I., Czernik C., Dudenhausen J.W., Henrich W., et al. Mirror syndrome: a systematic review of fetal associated conditions, maternal presentation and perinatal outcome. Fetal Diagn Therapy 2010, 27:191-203.
22. Jauniaux E., Van Maldergem L., DeMunter C., Moscoso G., Gillerot Y. Nonimmune hydrops fetalis associated with genetic abnormalities. Obstet Gynecol 1990, 75:568-572.
23. Has R. Non-immune hydrops fetalis in the first trimester: a review of 30 cases. Clin Exp Obstet Gynecol 2001, 28:187-190.
24. Wapner R.J., Driscoll D.A., Simpson J.L. Integration of microarray technology into prenatal diagnosis: counselling issues generated during the NICHD clinical trial. Prenat Diagn 2012, 32:396-400.
25. Knilans T.K. Cardiac abnormalities associated with hydrops fetalis. Semin Perinatol 1995, 19:483-492.
26. Bellini C., Hennekam R.C. Non-immune hydrops fetalis: a short review of etiology and pathophysiology. Am J Med Genet A 2012, 158:597-605.
27. de Jong E.P., Walther F.J., Kroes A.C., Oepkes D. Parvovirus B19 infection in pregnancy: new insights and management. Prenat Diagn 2011, 31:419-425.
28. Crino J.P. Ultrasound and fetal diagnosis of perinatal infection. Clin Obstet Gynecol 1999, 42:71-80. quiz 174-5.
29. Liao C., Xie X.M., Li D.Z. Two cases of homozygous alpha0-thalassemia diagnosed prenatally in pregnancies at risk for beta-thalassemia in China. Ultrasound Obstet Gynecol 2007, 29:474-475.
30. Negishi H., Yamada H., Okuyama K., Sagawa T., Makinoda S., Fujimoto S. Outcome of non-immune hydrops fetalis and a fetus with hydrothorax and/or ascites: with some trials of intrauterine treatment. J Perinat Med 1997, 25:71-77.
31. Yong P.J., von Dadelszen P., Carpara D., Lim K., Kent N., Tessier F., et al. Prediction of pediatric outcome after prenatal diagnosis and expectant antenatal management of congenital cystic adenomatoid malformation. Fetal Diagn Ther 2012, 31:94-102.
32. Isaacs H. Fetal hydrops associated with tumors. Am J Perinatol 2008, 25:43-68.
33. Norton M.E. Nonimmune hydrops fetalis. Semin Perinatol 1994, 18:321-332.
34. Kooper A.J., Janssens P.M., de Groot A.N., Liebrand-van Sambeek M.L., van den Berg C.J., Tan-Sindhunata G.B., et al. Lysosomal storage diseases in non-immune hydrops fetalis pregnancies. Clin Chim Acta 2006, 371:176-182.
35. Gort L., Granell M.R., Fernandez G., Carreto P., Sanchez A., Coll M.J. Fast protocol for the diagnosis of lysosomal diseases in nonimmune hydrops fetalis. Prenat Diagn 2012, 32:1139-1142.
36. L'Hermine-Coulomb A., Beuzen F., Bouvier R., Rolland R., Froissart M.O., Menez F., et al. Fetal type IV glycogen storage disease: clinical, enzymatic, and genetic data of a pure muscular form with variable and early antenatal manifestations in the same family. Am J Med Genet A 2005, 139:118-122.
37. Venkat-Raman N., Sebire N.J., Murphy K.W. Recurrent fetal hydrops due to mucopolysaccharidoses type VII. Fetal Diagn Ther 2006, 21:250-254.
38. Carvalho S., Martins M., Fortuna A., Ramos U., Ramos C., Rodrigues M.C. Galactosialidosis presenting as nonimmune fetal hydrops: a case report. Prenat Diagn 2009, 29:895-896.
39. Saudubray J., Van derBerghe G., Walter J. Inborn metabolic diseases: diagnosis and treatment. Berlin: Springer-Verlag; 2007.
40. Valayannopoulos V., Verhoeven N.M., Mention K., Salomons G.S., Sommelet D., Gonzales M., et al. Transaldolase deficiency: a new cause of hydrops fetalis and neonatal multi-organ disease. J Pediatr 2006, 149:713-717.
41. Burin M.G., Scholz A.P., Gus R., Sanseverino M.T., Fritsh A., Magalhães J.A., et al. Investigation of lysosomal storage diseases in nonimmune hydrops fetalis. Prenat Diagn 2004, 24:653-657.
42. Stone D.L., Sidransky E. Hydrops fetalis: lysosomal storage disorders in extremis. Adv Pediatr 1999, 46:409-440.
43. Huhta J.C. Guidelines for the evaluation of heart failure in the fetus with or without hydrops. Pediatr Cardiol 2004, 25:274-286.
44. Hernandez-Andrade E., Scheier M., Dezerega V., Carmo A., Nicolaides K.H. Fetal middle cerebral artery peak systolic velocity in the investigation of non-immune hydrops. Ultrasound Obstet Gynecol 2004, 23:442-445.
45. Mari G. Middle cerebral artery peak systolic velocity for the diagnosis of fetal anemia: the untold story. Ultrasound Obstet Gynecol 2005, 25:323-330.
46. Cosmi E., Dessole S., Uras L., Capobianco G., D'Antona D., Andrisani A., et al. Middle cerebral artery peak systolic and ductus venosus velocity waveforms in the hydropic fetus. J Ultrasound Med 2005, 24:209-213.
47. Hofstaetter C., Hansmann M., Eik-Nes S.H., Huhta J.C., Luther S.L. A cardiovascular profile score in the surveillance of fetal hydrops. J Matern Fetal Neonatal Med 2006, 19:407-413.
48. Pajkrt E., Weisz B., Firth H.V., Chitty L.S. Fetal cardiac anomalies and genetic syndromes. Prenat Diagn 2004, 24:1104-1115.
49. Eliasson H., Sonesson S.E., Sharland G., Granath F., Simpson J.M., Carvalho J.S., et al. Fetal Working Group of the European Association of Pediatric Cardiology. Isolated atrioventricular block in the fetus: a retrospective, multinational, multicenter study of 175 patients. Circulation 2011, 124:1919-1926.
50. Fouron J.C. Fetal arrhythmias: the Saint-Justine hospital experience. Prenat Diagn 2004, 24:1068-1080.
51. Berg C., Geipel A., Kohl T., Breuer J., Germer U., Krapp M., et al. Atrioventricular block detected in fetal life: associated anomalies and potential prognostic markers. Ultrasound Obstet Gynecol 2005, 26:4-15.
52. Klein J.O., Baker C.J., Remington J.S., Wilson C.B. Current concepts of infections of the fetus and newborn infant. In:. Infectious diseases of the fetus and newborn infant. Philadelphia: Elsevier Saunders; 2006, 3-25. J.S. Remington, J.O. Klein, C.B. Wilson, C.J. Baker (Eds.).
53. Mendelson E., Aboudy Y., Smetana Z., Tepperberg M., Grossman Z. Laboratory assessment and diagnosis of congenital viral infections: rubella, cytomegalovirus (CMV), varicella-zoster virus (VZV), herpes simplex virus (HSV), parvovirus B19 and human immunodeficiency virus (HIV). Reprod Toxicol 2006, 21:350-382.
54. Abdel-Fattah S.A., Bhat A., Illanes S., Bartha J.L., Carrington D. TORCH test for fetal medicine indications: only CMV is necessary in the United Kingdom. Prenat Diagnosis 2005, 25:1028-1031.
55. Enders M., Weidner A., Zoellner I., Searle K., Enders G. Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases. Prenat Diagn 2004, 24:513-518.
56. Enders M., Schalasta G., Baisch C., Weidner A., Pukkila L., Kaikkonen L., et al. Human parvovirus B19 infection during pregnancy--value of modern molecular and serological diagnostics. J Clin Virol 2006, 35:400-406.
57. Crane J. SOGC Fetal Medicine Committee. Parvovirus B19 infection in pregnancy. SOGC Clinical Practice Guidelines, No. 119, September 2002. J Obstet Gynaecol Can 2002, 24:727-743. quiz 44-6.
58. Yinon Y., Farine D., Yudin M.H., Gagnon R., Hudon L., Basso M., et al. SOGC Fetal Medicine Committee. Cytomegalovirus infection in pregnancy. SOGC Clinical Practice Guidelines, No. 240, April 2010. J Obstet Gynaecol Can 2010, 32:348-354.
59. Yinon Y., Farine D., Yudin M.H. Screening, diagnosis, and management of cytomegalovirus infection in pregnancy. Obstet Gynecol Surv 2010, 65:736-743.
60. Lazzarotto T., Gabrielli L., Foschini M.P., Lanari M., Guerra B., Eusebi V., et al. Congenital cytomegalovirus infection in twin pregnancies: viral load in the amniotic fluid and pregnancy outcome. Pediatrics 2003, 112:153-157.
61. Harger J.H., Ernest J.M., Thurnau G.R., Moawad A., Thom E., Landon M.B., et al. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Frequency of congenital varicella syndrome in a prospective cohort of 347 pregnant women. Obstet Gynecol 2002, 100:260-265.
62. Mouly F., Mirlesse V., Meritet J.F., Rozenberg F., Poissonier M.H., Lebon P. et al. Prenatal diagnosis of fetal varicella-zoster virus infection with polymerase chain reaction of amniotic fluid in 107 cases. Am J Obstet Gynecol 1997, 177:894-898.
63. Bachmaier N., Fusch C., Stenger R.D., Grabow D., Mentel R., Warzok R. Nonimmune hydrops fetalis due to enterovirus infection. Eur Jour Obstet Gynecol Reprod Biol 2009, 142:83-84.
64. Langlois S., Ford J.C., Chitayat D., Desilets V.A., Farrell S.A., Geraghty M. et al.; CCMG Prenatal Diagnosis Committee; SOGC Genetics Committee. Carrier screening for thalassemia and hemoglobinopathies in Canada. J Obstet Gynaecol Can 2008, 30:950-971.
65. Dwinnell S.J., Coad S., Butler B., Albersheim S., Wadsworth L.D., Wu J.K., et al. In Utero diagnosis and management of a fetus with homozygous a-Thalassemia in the second trimester: a case report and literature review. J Pediatr Hematol Oncol 2011, 33:358-360.
66. Ramsay S.L., Maire I., Bindloss C., Fuller M., Whitfield P.D., Piraud M., et al. Determination of oligosaccharides and glycolipids in amniotic fluid by electrospray ionisation tandem mass spectrometry: in utero indicators of lysosomal storage diseases. Mol Genet Metab 2004, 83:231-238.
67. Edwards M., McKenzie F., O'Callaghan S., Somerset D., Woodford P., Spilsbury J., et al. Prenatal diagnosis of congenital disorder of glycosylation type Ia (CDG-Ia) by cordocentesis and transferrin isoelectric focussing of serum of a 27-week fetus with non-immune hydrops. Prenat Diagn 2006, 26:985-988.
68. Acar A., Balci O., Gezginc K., Onder C., Capar M., Zamani A., et al. Evaluation of the results of cordocentesis. Taiwan J Obstet Gynecol 2007, 46:405-409.
69. Gedikbasi A., Oztarhan K., Gunenc Z., Yildirim G., Arslan O., Yildirim D., et al. Preeclampsia due to fetal non-immune hydrops: mirror syndrome and review of literature. Hypertens Pregnancy 2011, 30:322-330.
70. Kelly T., Mathers A. Early presentation and spontaneous resolution of hydrops fetalis, secondary to parvovirus B19 infection. J Obstet Gynaecol 1998, 18:190-191.
71. Iskaros J., Jauniaux E., Rodeck C. Outcome of nonimmune hydrops fetalis diagnosed during the first half of pregnancy. Obstet Gynecol 1997, 90:321-325.
72. Ayida G.A., Soothill P.W., Rodeck C.H. Survival in non-immune hydrops fetalis without malformation or chromosomal abnormalities after invasive treatment. Fetal Diagn Ther 1995, 10:101-105.
73. Abrams M.E., Meredith K.S., Kinnard P., Clark R.H. Hydrops fetalis:a retrospective review of cases reported to a large national database and identification of risk factors associated with death. Pediatrics 2007, 120:84-89.
74. Huang H.R., Tsay P.K., Chiang M.C., Lien R., Chou Y.H. Prognostic factors and clinical features in liveborn neonates with hydrops fetalis. Am J Perinatol 2007, 24:33-38.
75. Breur J.M., Gooskens R.H., Kapusta L., Stoutenbeek P., Visser G.H., van den Berg P., et al. Neurological outcome in isolated congenital heart block and hydrops fetalis. Fetal Diagn Ther 2007, 22:457-461.
76. Rodriguez M.M., Bruce J.H., Jimenez X.F., Romaguera R.L., Bancalari E., Garcia O.L., et al. Nonimmune hydrops fetalis in the liveborn: series of 32 autopsies. Pediatric and developmental pathology 2005, 8:369-378.
77. Knisely A.S. The pathologist and the hydropic placenta, fetus, or infant. Semin Perinatol 1995, 19:525-531.
78. Woolf S.H., Battista R.N., Angerson G.M., Logan A.G., Eel W. Canadian Task Force on Preventive Health Care. New grades for recommendations from the Canadian Task Force on Preventive Health Care. CMAJ 2003, 169:207-208.